BiotechTube
Home/SyzOnc/T. S. Karin Eisinger, PhD
TS

T. S. Karin Eisinger, PhD

Co-founder & CEO

SyzOnc

Therapeutic Areas

OncologyImmunology

SyzOnc Pipeline

DrugIndicationPhase
STEM³ Platform Validation & Target DiscoveryMatrix-rich solid tumors (e.g., Sarcoma)Discovery

Leadership Team at SyzOnc

AM
Ashley M. Fuller, PhD
Co-founder & CSO
AC
Anne Carpenter, PhD
Co-founder & Chair of SAB
AM
Arindam Mondal, PhD
Senior Scientist
View full SyzOnc profile